Effects of High Glucose on AVP-Induced Hyperplasia, Hypertrophy, and Type IV Collagen Synthesis in Cultured Rat Mesangial Cells

REFERENCES

• Lane PH, Steffes MW, Mauer SM. Renal histologic changes in diabetes mellitus. Semin Nephrol 1990;10:254–259.
   Web of Science ®Google Scholar
• Kreisberg JI, Ayo SH. The glomerular mesangium in diabetes mellitus. Kidney Int 1993;43:109–113.
   PubMed Web of Science ®Google Scholar
• Mauer SM, Steffes MW, Brown DM. The kidney in diabetes. Am J Med 1981;70:603–612.
   PubMed Web of Science ®Google Scholar
• Abrass CK, Peterson CV, Raugi GJ. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 1988;37:1695–1702.
   PubMed Web of Science ®Google Scholar
• Kleinman KS, Fine LG. Prognostic implications of renal hypertrophy in diabetes mellitus. Diabetes Metab Rev 1988;4:179–189.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal diseases. Miner Electrolyte Metab 1995;21:292–302.
   PubMedGoogle Scholar
• Ayo SH, Radnik RA, Glass WF 2nd, Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991;260:F185–F191.
   PubMed Web of Science ®Google Scholar
• Wakisaka M, Spiro MJ, Spiro RG. Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 1994;43:95–103.
   PubMed Web of Science ®Google Scholar
• Pugliese G, Pricci F, Pugliese F, Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 1994;43:478–490.
   PubMed Web of Science ®Google Scholar
• Haneda M, Koya D, Isono M, Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 2003;14:1374–1382.
   PubMed Web of Science ®Google Scholar
• Ayo SH, Radnik R, Garoni JA, High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 1991;261:F571–F577.
   Google Scholar
• Craven PA, DeRubertis FR. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 1989;83:1667–1675.
   PubMed Web of Science ®Google Scholar
• Koya D, Jirousek MR, Lin YW, Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 1997;100:115–126.
   PubMed Web of Science ®Google Scholar
• Rebibou JM, He CJ, Delarue F, Functional endothelin 1 receptors on human glomerular podocytes and mesangial cells. Nephrol Dial Transplant 1992;7:288–292.
   PubMed Web of Science ®Google Scholar
• Chansel D, Czekalski S, Pham P, Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol 1992;262:F432–F441.
   Google Scholar
• Thibonnier M, Bayer AL, Leng Z. Cytoplasmic and nuclear signaling pathways of V1-vascular vasopressin receptors. Regul Pept 1993;45:79–84.
   PubMed Web of Science ®Google Scholar
• Tahara A, Tsukada J, Tomura Y, Effect of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy. Vascul Pharmacol 2007;46:463–469.
   Google Scholar
• Tahara A, Tsukada J, Tomura Y, Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells. Clin Exp Pharmacol Physiol 2008;35:586–593.
   Google Scholar
• Tsukada J, Tahara A, Tomura Y, Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist. Vascul Pharmacol 2005;42:47–55.
   Google Scholar
• Serradeil-Le Gal C, Wagnon J, Garcia C, Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors. J Clin Invest 1993;92:224–231.
   PubMed Web of Science ®Google Scholar
• Yamamura Y, Ogawa H, Yamashita H, Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol 1992;105:787–791.
   PubMed Web of Science ®Google Scholar
• Serradeil-Le Gal C, Lacour C, Valette G, Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest 1996;98:2729–2738.
   PubMed Web of Science ®Google Scholar
• Kohno M, Horio T, Ikeda M, Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int 1992;42:860–866.
   PubMed Web of Science ®Google Scholar
• Li W, Shen S, Khatami M, Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high-glucose concentration. Diabetes 1984;33:785–789.
   Google Scholar
• Lorenzi M, Nordberg JA, Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 1987;36:1261–1267.
   PubMedGoogle Scholar
• Cosio FG. Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol 1995;5:1600–1609.
   PubMed Web of Science ®Google Scholar
• Choi KH, Kang SW, Lee HY, The effects of high glucose concentration on angiotensin II- or transforming growth factor-beta-induced DNA synthesis, hypertrophy and collagen synthesis in cultured rat mesangial cells. Yonsei Med J 1996;37:302–311.
   Google Scholar
• Abboud HE, Throckmorton D, Weinshell E, Differential modulation of mesangial cell proliferation by peptide growth factors and cyclic adenosine monophosphate (cAMP). FASEB J 1988;2:A627.
   Google Scholar
• Appel RG. Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEBS Lett 1988;238:135–138.
   PubMed Web of Science ®Google Scholar
• Diamond JR, Karnovsky MJ. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Ren Physiol 1986;9:366–374.
   Google Scholar
• Massague J. The TGF-beta family of growth and differentiation factors. Cell 1987;49:437–438.
   PubMed Web of Science ®Google Scholar
• Mene P, Dunn MJ. Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int 1990;37:1256–1262.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Goldfarb S, Kern EFO. Diabetic nephropathy: metabolic and biochemical mechanisms. In: Contemporary Issues in Nephrology 20. The Kidney in Diabetes Mellitus. New York: Churchill Livingstone; 1989:87–113 edited by Brenner BM and Stein JH.
   Google Scholar
• Haneda M, Kikkawa R, Horide N, Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 1991;34:198–200.
   PubMedGoogle Scholar
• Blatti SP, Foster ND, Ranganathan G, Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation ofAKR-2B cells. Proc Natl Acad Sci USA 1988;85:1119–1123.
   PubMed Web of Science ®Google Scholar
• Czaja MJ, Weiner FR, Eghbali MA, Differential effects of gamma-interferon on collagen and fibronectin gene expression. J Biol Chem 1987;262:13348–13351.
   PubMed Web of Science ®Google Scholar
• Lanser ME, Browin GE. Stimulation of rat hepatocyte fibronectin production by monocyte-conditioned medium is due to interleukin 6. J Exp Med 1989;170:1781–1786.
   Google Scholar
• Craven PA, Davidson CM, DeRubertis FR. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 1990;39:667–674.
   PubMed Web of Science ®Google Scholar
• Blenis J. Signal transduction via the MAP kinase: proceed at your own RSK. Proc Natl Acad Sci USA 1993;90:5889–5892.
   PubMed Web of Science ®Google Scholar
• Haneda M, Araki S, Togawa M, Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 1997;46:847–853.
   PubMed Web of Science ®Google Scholar
• Studer RK, Negrete H, Craven PA, Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells. Kidney Int 1995;48:422–430.
   PubMed Web of Science ®Google Scholar
• Border WA, Yamamoto T, Noble NA. Transforming growth factor-beta in diabetic nephropathy. Diabetes Metab Rev 1996;12:309–339.
   Google Scholar
• Ziyadeh FN, Han DC. Involvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology. Kidney Int Suppl 1997;60:S7–S11.
   PubMedGoogle Scholar
• Hoffman BB, Sharma K, Zhu Y, Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int 1998;54:1107–1116.
   PubMed Web of Science ®Google Scholar
• Oh JH, Ha H, Yu MR, Sequential effects of high glucose on mesangial cell transforming growth factor-beta1 and fibronectin synthesis. Kidney Int 1998;54:1872–1878.
   Google Scholar
• Ziyadeh FN, Sharma K, Ericksen M, Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994;93:536–542.
   PubMed Web of Science ®Google Scholar